Through the 90-day period concluding February 10, 2026, Apellis Pharmaceuticals's top three insider stakeholders include TenPercentOwner Venture Investments Ltd Morningside (12.81Mn shares), Chief Scientific Officer Pascal Deschatelets (1.18Mn shares), Chief Executive Officer Cedric Francois (798.78K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Venture Investments Ltd Morningside | 12,806,342 | 18 Nov, 2021 | |
| Pascal Deschatelets | Chief Scientific Officer | 1,177,222 | 30 Jan, 2026 |
| Cedric Francois | Chief Executive Officer | 798,783 | 05 Feb, 2026 |
| Alec Machiels | 396,939 | 05 Jan, 2026 | |
| Timothy Eugene Sullivan | Chief Financial Officer | 212,437 | 30 Jan, 2026 |
| David O. Watson | General Counsel | 194,653 | 30 Jan, 2026 |
| A. Sinclair Dunlop | 191,709 | 05 Jan, 2026 | |
| Kelley Boucher | Chief People Officer | 127,804 | 30 Jan, 2026 |
| Nur Nicholson | Chief Technical Officer | 116,338 | 30 Jan, 2026 |
| Mark Jeffrey Delong | Chief Business & Strat Officer | 114,959 | 30 Jan, 2026 |
| Leslie Meltzer | Chief Research And Development | 107,024 | 30 Jan, 2026 |
| Federico Grossi | Chief Medical Officer | 94,884 | 09 Jan, 2023 |
| Caroline Baumal | Chief Medical Officer | 86,527 | 23 Jan, 2026 |
| Adam J. Townsend | Chief Commercial Officer | 84,050 | 30 Jan, 2025 |
| Karen Lewis | Chief People Officer | 70,251 | 30 Jan, 2025 |
| Lukas Scheibler | Chief Research Officer | 68,299 | 05 Dec, 2023 |
| James George Chopas | Vp/Chief Accounting Officer | 65,955 | 30 Jan, 2026 |
| Jeffrey Eisele | Chief Development Officer | 55,312 | 30 Jan, 2025 |
| Paul R. Fonteyne | 30,666 | 05 Jan, 2026 | |
| Stephanie Monaghan O'Brien | 25,666 | 05 Jan, 2026 | |
| Gerald Chan | 25,666 | 05 Jan, 2026 | |
| Craig A Wheeler | 24,444 | 05 Jan, 2026 | |
| Victoria L. Brown | Program Team Lead | 23,556 | 24 Jan, 2023 |
| Keli Walbert | 17,051 | 05 Jan, 2026 | |
| Nicole D Perry | Vice President Accounting | 4,847 | 03 Aug, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 03 Feb, 2026 | Cedric Francois | Common Stock | A | 8,840 | $3.76 | 490,837 | D | M |
| 28 Jan, 2026 | David O. Watson | Common Stock | A | 55,986 | $0.00 | 144,517 | D | A |
| 28 Jan, 2026 | Pascal Deschatelets | Common Stock | A | 25,840 | $0.00 | 1,177,222 | D | A |
| 28 Jan, 2026 | Cedric Francois | Common Stock | A | 195,952 | $0.00 | 481,997 | D | A |
| 28 Jan, 2026 | Timothy Eugene Sullivan | Common Stock | A | 58,140 | $0.00 | 152,041 | D | A |
| 28 Jan, 2026 | Nur Nicholson | Common Stock | A | 45,220 | $0.00 | 116,338 | D | A |
| 28 Jan, 2026 | James George Chopas | Common Stock | A | 16,150 | $0.00 | 65,955 | D | A |
| 28 Jan, 2026 | Mark Jeffrey Delong | Common Stock | A | 36,606 | $0.00 | 114,959 | D | A |
| 28 Jan, 2026 | Kelley Boucher | Common Stock | A | 30,146 | $0.00 | 127,804 | D | A |
| 28 Jan, 2026 | Leslie Meltzer | Common Stock | A | 45,220 | $0.00 | 107,024 | D | A |
| 22 Jan, 2026 | David O. Watson | Common Stock | D | 7,832 | $21.77 | 88,531 | D | S |
| 22 Jan, 2026 | Pascal Deschatelets | Common Stock | D | 5,928 | $21.77 | 1,151,382 | D | S |
| 22 Jan, 2026 | Cedric Francois | Common Stock | D | 27,192 | $21.77 | 286,045 | D | S |
| 22 Jan, 2026 | Timothy Eugene Sullivan | Common Stock | D | 10,287 | $21.77 | 93,901 | D | S |
| 22 Jan, 2026 | Nur Nicholson | Common Stock | D | 7,725 | $21.77 | 71,118 | D | S |
| 22 Jan, 2026 | James George Chopas | Common Stock | D | 2,064 | $21.77 | 49,805 | D | S |
| 22 Jan, 2026 | Mark Jeffrey Delong | Common Stock | D | 3,371 | $21.77 | 78,353 | D | S |
| 22 Jan, 2026 | Caroline Baumal | Common Stock | D | 2,797 | $21.77 | 86,527 | D | S |
| 20 Jan, 2026 | David O. Watson | Common Stock | D | 2,475 | $19.79 | 96,363 | D | S |
| 20 Jan, 2026 | Pascal Deschatelets | Common Stock | D | 909 | $19.79 | 1,157,310 | D | S |